Form 4: Vaxart Director Michael J. Finney Reports Acquisition of Shares and Stock Options

Director Michael J. Finney reports acquisition of 16,000 shares of common stock and 95,400 stock options in Vaxart, Inc.

Summary

• On June 11, 2024, Michael J. Finney, a director of Vaxart, Inc., reported acquiring 16,000 shares of common stock due to the vesting of restricted stock units.
• Finney also acquired 95,400 stock options with an exercise price of $0.77.
• These options vest on the earlier of the date immediately prior to the 2025 annual meeting of stockholders or June 11, 2025, and expire on June 11, 2034.
• Following these transactions, Finney directly owns 686,840 shares of Vaxart common stock and 95,400 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which can be interpreted as a positive sign of confidence, but without further context, it's difficult to gauge the overall impact.

Positives

• The acquisition of shares and options by a director could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive signal.

Key Dates